Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysisGiuseppe Fallara, Alberto Martini, Francesco Montorsi et al.|Cancer Treatment Reviews|2022Cited by 33
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysisGiuseppe Fallara, Alberto Martini, Daniele Raggi et al.|Critical Reviews in Oncology/Hematology|2022Cited by 13
A Plea for Economically Sustainable Evidence-based GuidelinesAlberto Martini, Bernard Malavaud, Nicolas Mottet et al.|European Urology|2022Cited by 11
Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate CancerGiuseppe Fallara, Alberto Martini, Daniele Robesti et al.|European Urology Open Science|2023Cited by 8
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violationLuigi Nocera, Alberto Martini, Giuseppe Fallara et al.|Frontiers in Oncology|2022Cited by 7